The conference highlighted recent advances in the diagnosis and management of obesity, endocrine disorders, diabetes, and growth hormone and thyroid diseases.
Offering choice of CRC screening increases completion rates
May 21, 2024
The rate of colorectal cancer screening improved within six months for those offered fecal immunochemical testing only or a choice of coloscopy or FIT.
Decline seen in patients undergoing surgery for colon, rectal cancer in 2020
Apr 11, 2024
Patients undergoing surgery in 2020 versus 2019 had a more advanced clinical and pathological tumor stage.
Heart, diabetes, cancer drugs on list for Medicare price negotiations, White House says
Aug 29, 2023
Enrollees in the Medicare prescription drug program paid a total of $3.4 billion in out-of-pocket costs in 2022 for the 10 initial drugs chosen for price negotiations.
1996 to 2020 saw cancer death rates drop across congressional districts
May 16, 2023
The smallest percent of relative declines was seen in the Midwest and Appalachia, whereas the largest declines were seen in the South along the East Coast and southern border.
>10 percent of FIT are unsatisfactory and cannot be processed
Nov 22, 2023
Fewer than half of those with an unsatisfactory FIT completed a subsequent test within 15 months.
Menopausal hormone therapy use beyond 65 years beneficial
Apr 16, 2024
Use of menopausal hormone therapy beyond age 65 years is associated with risk reductions in mortality as well as specific cancers and cardiovascular diseases, according to a study published online April...
Per-patient costs of metastatic prostate cancer estimated at $31,427
Dec 27, 2022
An increase in annual attributable costs was observed over time, from $28,311 in 2007-2013 to $37,055 in 2014-2017.
Aggressive end-of-life care often used in seniors with metastatic cancer
Feb 24, 2023
Aggressive end-of-life care used more often by nursing home residents than community-dwelling residents aged 66 years or older
In continuing trend, AI shows new strong promise in specific cancer diagnoses, research shows
By
Aaron Dorman
Nov 22, 2023
AI assisted pancreatic and breast cancer detection were the focus of separate studies published this week in Nature Medicine.